TruthArchive.ai - Related Video Feed

We have a prevention protocol and an early treatment protocol. In the early treatment protocol, we use Ivermectin, which is not a horse dewormer. The claim that it's toxic is a complete lie. Over 3.7 billion doses of Ivermectin have been given to humans, making it one of the most influential drugs after penicillin. It is completely safe, even safer than Tylenol. While its efficacy can be debated, if you have limited options and a sick patient, why not try a safe and affordable drug like Ivermectin? There's nothing to lose.

There is a drug called Ivermectin that has proven to be highly effective in combating the current crisis. This is not an exaggeration, but a scientific recommendation based on extensive data gathered over the past three months. The NIH's recommendation against using Ivermectin outside of controlled trials was made in August, but since then, numerous studies from various countries have shown its miraculous impact. It has been found to completely prevent the transmission of the virus and ensure that individuals who take it do not get sick.

At home, it is recommended to treat viral replication by giving remedies like zinc and hydroxychloroquine, ivermectin, which reduce the spread of the disease. However, the protocol followed was different. No treatment was given until hospitalization, where ventilators and Remdesivir were used. It is known that Remdesivir can be harmful, as it caused side effects in Ebola patients. The drug was manipulated and made standard of care, leading to kidney failure, heart failure, and organ collapse in COVID-19 patients. The deaths during the pandemic were often attributed to kidney failure, which was caused by Remdesivir, not the virus itself.

200 congresspeople have been treated with Ivermectin for COVID, which was a common off-label treatment before vaccines were available. The motivation behind the negative perception of this medication is unclear, but it may relate to financial interests since Ivermectin is a generic drug with a low cost of about 30 cents per dose.

In 2002-2003, North American science conducted experiments and research on the original SARS CoV-one. By 2015-2016, it was known that Ivermectin and hydroxychloroquine were effective against viruses and could modulate the immune response. DARPA, the American Research Arm of the U.S. Military, recommended Ivermectin to the CDC as the top product for a coronavirus pandemic. These medications have been used safely in humans for 35 to 40 years. So, when the next pandemic hit, Ivermectin was ready to be used.

There are numerous studies showing the significant benefits of Ivermectin, with a 70 to 85% reduction in hospitalizations and deaths. It has been effective worldwide, including in countries like Nigeria, which has the highest burden of river blindness but the lowest COVID death rate. They use both Ivermectin and hydroxychloroquine. Similarly, states in India like Kerala and Uttar Pradesh had comparable death rates by following a protocol that included Ivermectin and hydroxychloroquine. There are over 400 studies supporting the benefits of hydroxychloroquine and nearly 100 studies showing the devastating benefits of Ivermectin. However, a few government-produced studies financed by Bill Gates and the WHO claim no benefit, but these studies have been criticized.

Ivermectin has shown effectiveness in preventing COVID-19 infection, as evidenced by a trial in Argentina where 800 healthcare workers were prophylaxed and none got sick, compared to 58% of those who were not given Ivermectin. It has also demonstrated antiviral activity and has been proven effective as a prophylaxis agent in four large randomized controlled trials. In early outpatient treatment, it reduces the need for hospitalization and death, as shown in three randomized controlled trials and multiple case series. In hospitalized patients, Ivermectin has consistently shown lower mortality rates in four randomized controlled trials. It has already won the Nobel Prize in Medicine in 2015 for its impact on global health.

Over 100 studies have shown that Ivermectin has had significant benefits, reducing hospitalizations and deaths by 70 to 85%. It was effective worldwide, including in Nigeria, where they used it for river blindness and had the lowest COVID death rate. Similarly, states in India like Kerala and Uttar Pradesh used our protocol with Ivermectin and hydroxychloroquine, ending the pandemic overnight. There are around 400 studies supporting the benefits of hydroxychloroquine and nearly 100 studies showing the devastating benefits of Ivermectin. However, a few government-produced studies financed by Bill Gates and the WHO claim no benefit, but these studies have been criticized.

In 2020, there was a disinformation campaign against Hydroxychloroquine, a generic drug. The pharmaceutical industry opposes generic drugs as they reduce profits. They conducted trials with toxic doses of Hydroxychloroquine, causing increased deaths. On the other hand, Ivermectin is beneficial when given in higher doses. The spike protein in COVID-19 causes clotting issues and suppresses interferon, a chemical that helps fight infections and cancer. Medicines like Ivermectin and others can boost interferon levels and prevent clotting by binding to receptors. Some patients given high doses of Ivermectin have shown remarkable recovery, as it competes with the spike protein for binding sites and prevents clot formation.

Multiple studies, including one by the WHO, show that Remdesivir actually increases the risk of death. It's concerning that the federal government incentivizes hospitals to prescribe this toxic drug by offering a 20% bonus on the entire hospital bill for Medicare patients. Remdesivir costs around $3,000 per course. On the other hand, Ivermectin, as mentioned by Dr. Kory, reduces the risk of death by about 50%. Unfortunately, clinicians still use the wrong drug, Dexamethasone, in the wrong dose and for the wrong duration of time, simply because the NIH recommends it. The NIH and other agencies have disregarded multiple FDA-approved drugs that are both cost-effective and safe.

Tony Fauci's problem is that a federal law prohibits emergency use authorization for a vaccine if there is an approved medication that effectively treats the target disease. If Fauci or anyone had acknowledged that Ivermectin works as a treatment for COVID, the vaccine would not have received authorization. Despite many doctors and publications supporting Ivermectin, Fauci actively dismissed it as a dangerous medication to drown out its effectiveness. It is unclear why he continued to do so after receiving authorization, but there is a strong incentive for him to discredit Ivermectin and hydroxychloroquine. Notable doctors like Harvey Reich and Pierre Cory have successfully treated thousands of COVID patients.

We discovered that Ivermectin can kill COVID-19 in primate cells. A single dose of the drug stopped the virus from replicating within 48 hours. Human trials are on the horizon, as the drug has been safely used for decades. Repurposing existing drugs like Ivermectin can speed up development by utilizing known safety profiles and administration methods. We are working on determining if these benefits can translate to treating COVID-19 in humans.

At home, it is recommended to treat viral replication by giving zinc and other zinc-enhancing remedies like hydroxychloroquine and Ivermectin. However, the protocol followed by hospitals was to provide no treatment until admission, and then use ventilators and Remdesivir, which were known to be harmful. Tony Fauci was aware of the dangers of Remdesivir, as it caused lethal side effects in Ebola patients. Despite this, he manipulated a study to make Remdesivir the standard of care, resulting in kidney failure, heart failure, and organ collapse in COVID-19 patients. The deaths attributed to the virus were actually caused by Remdesivir.

Ivermectin is a widely used and safe drug that has been effective against SARS CoV 2. It could have saved many lives if it had been used more widely. Doctors who tried to use it faced prosecution, despite its safety and effectiveness. One doctor worked 715 continuous days without a day off because no one else wanted to care for indigent patients. The doctor's hospital had a low mortality rate compared to the rest of the country, thanks to protocols that included Ivermectin. However, the media ignored their success and the use of repurposed drugs. The doctor faced censorship on social media platforms for mentioning Ivermectin. The FDA claims there are no adequate alternatives to the vaccines, but many believe unnecessary deaths occurred due to censorship and lack of access to Ivermectin.

The North American scientific community spent 15 years planning for the next Covid epidemic. In 2000-2003, SARS-CoV-1 emerged, leading to various experiments to determine the best response for a similar event. By 2015-2016, research was completed, and the US military's research branch, DARPA, specifically recommended and informed the CDC that ivermectin was the top product to use in a coronavirus pandemic. It was known that ivermectin and hydroxychloroquine were highly antiviral and immunomodulatory. These elements were proven effective in stimulating the immune response and fighting viruses in both lab and animal studies. These drugs have been used safely in humans for 35-40 years, making them ready for the next pandemic.

North American science spent 15 years researching how to respond to a future coronavirus pandemic after the original SARS CoV-one outbreak in 2002-2003. By 2015-2016, research showed that Ivermectin and Hydroxychloroquine were effective antiviral and immune modulatory treatments. The US military's research arm, DARPA, recommended Ivermectin as the top choice for a coronavirus pandemic and shared this information with the CDC. These medications had been proven safe for humans and had been used for several decades. They were ready to be used in the event of a future pandemic.

North American science spent 15 years preparing for the next COVID after the original SARS CoV 1 outbreak in 2002-2003. By 2015-2016, research was complete. DARPA recommended to the CDC that ivermectin was the number one product to use in the event of a coronavirus pandemic. Ivermectin and hydroxychloroquine were known to be highly antiviral and immune modulatory. These effects were proven in vitro and in vivo with animals. Both medications were known to be completely safe for humans, having been used for 35 to 40 years. This knowledge was readily available for use at the next pandemic.

Over 100 studies have shown that Ivermectin has had significant benefits, reducing hospitalizations and deaths by 70 to 85%. It has been widely used around the world, including in Nigeria, where it helped lower the COVID death rate. Kerala and Uttar Pradesh states in India also used Ivermectin and hydroxychloroquine, effectively ending the pandemic. Numerous studies, including 400 on hydroxychloroquine and nearly 100 on Ivermectin, demonstrate their benefits. However, a few government-funded studies, including those by the WHO and financed by Bill Gates, claim no benefits but have been criticized for their methodology. For more information, you can visit the websites of Dr. Meryl Masse or Yale epidemiologist Harvey Riesch.

Ivermectin, a Nobel Prize-winning anti-parasitic drug, has been vilified. Merck, who held the patent until 1996, claims it doesn't work for COVID-19. However, Merck has a 50/50 partnership with Moderna on mRNA cancer vaccines. Because Merck will make billions on mRNA cancer vaccines, they have no interest in investigating ivermectin for cancer. There is evidence that high-dose ivermectin is effective in treating many types of cancers.

The forest plot shows COVID medicines, with only expensive ones approved in the US. Cheaper drugs were ignored. Studies manipulated endpoints and faced negative PR. Over 420 trials on hydroxychloroquine and 100 on Ivermectin show significant benefits, but they are dismissed in the US.

A study on Ivermectin's effectiveness in reducing COVID-19 deaths has been peer-reviewed and published. The study analyzed excess deaths in Peru in 2020 and found that states with intensive Ivermectin use had a 74% reduction in excess deaths. When Ivermectin use was restricted, there was a 13-fold increase in deaths. The study concluded that Ivermectin showed strong evidence of effectiveness, considering potential confounding factors. The study was published on August 8th, 2022.

North American science spent 15 years researching how to respond to a potential coronavirus pandemic after the original SARS CoV-one outbreak in 2002-2003. By 2015-2016, it was known that Ivermectin and hydroxychloroquine were effective antiviral and immune modulatory treatments. DARPA, the American Research Arm of the U.S. Military, recommended Ivermectin to the CDC as the top product to use in a coronavirus pandemic. These medications had been proven safe for humans and had been used for several decades. So, when the next pandemic hit, North America had Ivermectin and hydroxychloroquine ready for use.

Patients were desperate for ivermectin as their loved ones died, but the focus shifted to remdesivir, a previously failed Ebola drug. By November 2020, the World Health Organization advised against its use, citing ineffectiveness and potential kidney and liver damage. The European Society of Critical Care supported this stance. Despite the warnings, the U.S. Health and Human Services incentivized hospitals with a 20% bonus for administering remdesivir, leading to widespread use. It failed to reduce mortality and caused serious injuries, with some patients dying as a result. In May 2022, the WHO reaffirmed its initial decision, stating that remdesivir should never have been used.

Multiple trials have been conducted on Ivermectin, but none have proven its effectiveness, according to Speaker 0. However, Speaker 1 argues that there is a significant body of evidence, including randomized controlled trials and studies, supporting the use of Ivermectin for COVID. They mention countries like India, Mexico, and nations in Central Africa, as well as the Tokyo Medical Association endorsing its use. While some doctors and scientists have criticized certain trial methodologies, claiming that there is no science to support Ivermectin for COVID is false. Speaker 1 also highlights that experienced critical care doctors worldwide have prescribed Ivermectin based on available data and their own expertise, dismissing the characterization of the drug as a horse dewormer. Speaker 2 adds that research conducted by DARPA in the early 2000s recommended Ivermectin as a top product for a coronavirus pandemic due to its antiviral and immune modulatory properties, which had been proven in vitro and in vivo. These medications have been safely used in humans for several decades.

Dr. Peterson Pierre from America's Frontline Doctors discusses the positive impact of Ivermectin on COVID-19 deaths in Peru and Uttar Pradesh, India. In Peru, the widespread use of Ivermectin resulted in a 74% reduction in excess deaths across 10 states. Similarly, in Uttar Pradesh, the distribution of Ivermectin led to a 97% decrease in COVID-19 deaths. The study suggests that Ivermectin can both prevent and treat the virus when distributed to at-risk populations. Dr. Pierre questions why more governments, including the US, did not adopt this strategy, emphasizing that Ivermectin is safe, effective, accessible, and affordable compared to experimental drugs. He suggests that fear mongering and financial interests may have influenced the decision-making process. Stay tuned for more updates.